IL117620A0 - Heterocyclic compounds processes for the preparation thereof and pharmaceutical compositions containing the same - Google Patents

Heterocyclic compounds processes for the preparation thereof and pharmaceutical compositions containing the same

Info

Publication number
IL117620A0
IL117620A0 IL11762096A IL11762096A IL117620A0 IL 117620 A0 IL117620 A0 IL 117620A0 IL 11762096 A IL11762096 A IL 11762096A IL 11762096 A IL11762096 A IL 11762096A IL 117620 A0 IL117620 A0 IL 117620A0
Authority
IL
Israel
Prior art keywords
preparation
same
pharmaceutical compositions
compositions containing
heterocyclic compounds
Prior art date
Application number
IL11762096A
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9506189.1A external-priority patent/GB9506189D0/en
Priority claimed from GBGB9511226.4A external-priority patent/GB9511226D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of IL117620A0 publication Critical patent/IL117620A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/54—Nitrogen and either oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/36—Sulfur atom
    • C07D473/38—Sulfur atom attached in position 6
IL11762096A 1995-03-27 1996-03-22 Heterocyclic compounds processes for the preparation thereof and pharmaceutical compositions containing the same IL117620A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9506189.1A GB9506189D0 (en) 1995-03-27 1995-03-27 Thiazole derivatives,process for production thereof and pharmaceutical compositions comprising the same
GBGB9511226.4A GB9511226D0 (en) 1995-06-02 1995-06-02 Heterocyclic compounds processes for production thereof and pharmaceutical compositions comprising the same

Publications (1)

Publication Number Publication Date
IL117620A0 true IL117620A0 (en) 1996-07-23

Family

ID=26306753

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11762096A IL117620A0 (en) 1995-03-27 1996-03-22 Heterocyclic compounds processes for the preparation thereof and pharmaceutical compositions containing the same

Country Status (3)

Country Link
AU (1) AU5015396A (en)
IL (1) IL117620A0 (en)
WO (1) WO1996030370A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4471404B2 (en) 1996-02-13 2010-06-02 アストラゼネカ ユーケイ リミテッド Quinazoline derivatives as VEGF inhibitors
PT885198E (en) 1996-03-05 2002-06-28 Astrazeneca Ab 4-ANYLINOQUINAZOLINE DERIVATIVES
GB9707800D0 (en) 1996-05-06 1997-06-04 Zeneca Ltd Chemical compounds
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
WO1998013350A1 (en) 1996-09-25 1998-04-02 Zeneca Limited Qinoline derivatives inhibiting the effect of growth factors such as vegf
AU8816298A (en) 1997-08-22 1999-03-16 Zeneca Limited Oxindolylquinazoline derivatives as angiogenesis inhibitors
US6262096B1 (en) 1997-11-12 2001-07-17 Bristol-Myers Squibb Company Aminothiazole inhibitors of cyclin dependent kinases
CA2344290C (en) 1998-10-08 2009-06-02 Astrazeneca Ab Quinazoline derivatives
US6414156B2 (en) 1998-10-21 2002-07-02 Bristol-Myers Squibb Company Process for preparing azacycloalkanoylaminothiazoles
US6214852B1 (en) 1998-10-21 2001-04-10 Bristol-Myers Squibb Company N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
EP1147094A1 (en) * 1999-01-15 2001-10-24 Novo Nordisk A/S Non-peptide glp-1 agonists
US6927214B1 (en) 1999-01-15 2005-08-09 Novo Nordisk A/S Non-peptide GLP-1 agonists
EE05330B1 (en) 1999-11-05 2010-08-16 Astrazeneca Ab Quinazoline derivatives as VEGF inhibitors
US6392053B2 (en) 1999-12-15 2002-05-21 Bristol-Myers Squibb Company Process for preparing arylacetylaminothiazoles
US6515004B1 (en) 1999-12-15 2003-02-04 Bristol-Myers Squibb Company N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
ES2267748T3 (en) 2000-04-07 2007-03-16 Astrazeneca Ab QUINAZOLINE COMPOUNDS.
US6919338B2 (en) * 2000-06-28 2005-07-19 Astrazeneca Ab Substituted quinazoline derivatives and their use as inhibitors of aurora-2 kinase
IL153947A0 (en) 2000-08-09 2003-07-31 Astrazeneca Ab Quinoline derivatives having vegf inhibiting activity
CN104003956A (en) * 2013-02-27 2014-08-27 中国药科大学 Thiazole compound, preparation method thereof and application in pharmacy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105767A (en) * 1977-03-28 1978-08-08 Merck & Co., Inc. Imidazo [1,2-a] pyridines substituted with a thienyl, thiazolyl, or thiadiazolyl group
TW205041B (en) * 1989-08-07 1993-05-01 Fujisawa Pharmaceutical Co
DE3929673A1 (en) * 1989-09-07 1991-03-14 Bayer Ag SUBSTITUTED CARBAMOYLTRIAZOLE

Also Published As

Publication number Publication date
WO1996030370A3 (en) 1996-11-28
AU5015396A (en) 1996-10-16
WO1996030370A2 (en) 1996-10-03

Similar Documents

Publication Publication Date Title
IL118369A0 (en) Piperazine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
IL116957A0 (en) Substituted heterocyclic compounds their preparation and pharmaceutical compositions containing them
AU6613996A (en) Heterocyclic compounds and pharmaceutical compositions containing them
IL116211A0 (en) Peptide compounds pharmaceutical compositions containing the same and processes for the preparation thereof
ZA9810490B (en) 2-Aryl-8-oxodihydropurine derivative process for the preparation thereof pharmaceutical composition containing the same and intermediate therefor
IL115484A0 (en) Polypeptide derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
IL115483A0 (en) Urea derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
IL110743A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
HUP9901159A3 (en) Substituted benzylaminopiperidine derivatives and use thereof, pharmaceutical compositions containing these compounds
ZA969248B (en) New aminoacid derivatives process for the manufacture thereof and pharmaceutical compositions containing thesse compounds
HUP9802086A3 (en) Pharmaceutical composition for piperidinoalkanol compounds
HUP9802999A3 (en) Pharmaceutical composition containing n-propargyl-1-aminoindan
ZA962916B (en) New arylglycineamide derivatives processes for the manufacture thereof and pharmaceutical compositions containing these compounds
IL112193A0 (en) Phenylpyrazolopyridine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
IL110376A0 (en) Pharmaceutical compositions containing ifetroban and methods for the preparation thereof
AP9701160A0 (en) Compounds and pharmaceutical compositions containing them
IL98873A0 (en) Benzodiazepine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL117620A0 (en) Heterocyclic compounds processes for the preparation thereof and pharmaceutical compositions containing the same
IL114670A0 (en) Guanidine derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
IL112443A0 (en) Heterocyclic compounds, their preparation and pharmaceutical compositions containing them
IL117495A0 (en) Beta-alanine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
IL108800A0 (en) Heterocyclic compounds, their preparation and pharmaceutical compositions containing them
IL107358A0 (en) a-Phosphonosulfonate derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
IL106385A0 (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
IL115272A0 (en) Asp-pallidipin pharmaceutical compositions containing the same and processes for the preparation thereof

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)